Inventor · disambiguated record
Leo Pavliv
Also filed as: PAVLIV LEO
40 granted patents·54 pending applications·253 citations·filing 1988–2025
98Inventor score
Files withCUMBERLAND PHARMACEUTICALS INC64PAVLIV LEO12CUMBERLAND PHARMACEUTICALS4UNIV VANDERBILT3COFFEY MATTHEW C2
Top patents by PatentIndex Score
94 records- 0194US8952065B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Feb 10, 2015·16 cites·9 claims
- 0294US8653061B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2014·17 cites·10 claims
- 0394US8399445B2Acetylcysteine composition and uses thereofPAVLIV LEO·Filed 2012·Granted Mar 19, 2013·17 cites·16 claims
- 0494US8148356B2Acetylcysteine composition and uses thereforPAVLIV LEO·Filed 2005·Granted Apr 3, 2012·22 cites·14 claims
- 0594US4929739AComplexes of tellurium and selenium derivativesUNIV BAR ILAN·Filed 1988·Granted May 29, 1990·41 cites·17 claims
- 0693US8722738B2Acetycysteine compositions and methods of use thereofPAVLIV LEO·Filed 2011·Granted May 13, 2014·18 cites·21 claims
- 0793US7605123B2Fatty acid formulations for oral delivery of proteins and peptides, and uses thereofBIOCON LTD·Filed 2005·Granted Oct 20, 2009·25 cites·15 claims
- 0891US9327028B2Acetylcysteine compositions and methods of use thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·12 cites·11 claims
- 0991US6727286B2Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acidCUMBERLAND PHARMACEUTICALS INC·Filed 2001·Granted Apr 27, 2004·31 cites·44 claims
- 1090US11806400B2Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Nov 7, 2023·2 cites·16 claims
- 1188US2025114334A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1286US9045728B2Liquid viral formulationsCOFFEY MATTHEW C·Filed 2011·Granted Jun 2, 2015·10 cites·35 claims
- 1385US9693998B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·4 cites·20 claims
- 1484US2024024481A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1584US2023381147A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1683US9610309B2Liquid viral formulationsONCOLYTICS BIOTECH INC·Filed 2015·Granted Apr 4, 2017·4 cites·32 claims
- 1782US9114068B2Treating patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·2 cites·14 claims
- 1880US9610352B2Lyophilized viral formulationsONCOLYTICS BIOTECH INC·Filed 2015·Granted Apr 4, 2017·3 cites·34 claims
- 1980US9072710B2Injectable ibuprofen formulationPAVLIV LEO·Filed 2012·Granted Jul 7, 2015·3 cites·37 claims
- 2079US9044498B2Lyophilized viral formulationsCOFFEY MATTHEW C·Filed 2011·Granted Jun 2, 2015·4 cites·37 claims
- 2178US12161632B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 2278US11571412B2Thromboxane receptor antagonists in AERD/asthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Feb 7, 2023·0 cites·4 claims
- 2378US10314824B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·1 cites·9 claims
- 2478US10064845B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·2 cites·22 claims
- 2577US9072661B2Injectable ibuprofen formulationPAVLIV LEO·Filed 2012·Granted Jul 7, 2015·4 cites·28 claims
- 2677US8778907B2Lactulose for bowel evacuationPAVLIV LEO·Filed 2011·Granted Jul 15, 2014·1 cites·38 claims
- 2777US2022133696A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2877US2020121793A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2976US9931311B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Apr 3, 2018·1 cites·7 claims
- 3076US9012508B2Administration of intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted Apr 21, 2015·2 cites·5 claims
- 3176US8735452B2Treating patients with intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted May 27, 2014·1 cites·16 claims
- 3276US2025049764A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3376US2022211674A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3476US2022218672A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3575US8871810B2Treating critically ill patients with intravenous ibuprofenPAVLIV LEO·Filed 2009·Granted Oct 28, 2014·1 cites·13 claims
- 3674US8933115B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·1 cites·27 claims
- 3774US8563685B2Fatty acid formulations and oral delivery of proteins and peptides, and uses thereofRADHAKRISHNAN BALASINGAM·Filed 2009·Granted Oct 22, 2013·1 cites·12 claims
- 3874US2020375953A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3973US9649284B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted May 16, 2017·1 cites·19 claims
- 4073US9138404B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·1 cites·20 claims
- 4173US2021137895A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4273US2025235539A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4373US2021106561A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4472US10925860B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Feb 23, 2021·0 cites·7 claims
- 4572US9295639B2Treating critically ill patients with intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted Mar 29, 2016·1 cites·16 claims
- 4672US2020316022A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4771US2021015798A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4871US2020171007A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4970US2020253935A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 5069US10583126B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·0 cites·7 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →